Therapy of metastatic malignant melanoma using xomazyme® Mel, a murine monoclonal anti-melanoma ricin A chain immunotoxin
International Journal of Radiation Applications and Instrumentation. Part B. Nuclear Medicine and Biology - Tập 16 - Trang 625-627 - 1989
Tài liệu tham khảo
LoBuglio, 1988, Pharmacokinetics and immune response to Xomazyme-Mel in melanoma patients, Antibody Immunoconjugates and Radiopharmaceuticals, 1, 305
Spitler, 1987, Therapy of patients with malignant melanoma using a monoclonal antimelanoma antibody-ricin A chain immunotoxin, Cancer Res., 47, 1717